维普中文期刊产品整合服务
10篇 您的检索式:作者名="James IM"
    题名 作者 年代 出处 被引量
1The Appendix May Protect Against Clostridium difficile Recurrence显示文摘Gene Y. Im Rani J. Modayil Cheng T. Lin Steven J. Geier Douglas S. Katz Martin Feuerman James H. Grendell 2011Clinical Gastroenterology and Hepatology2011,,12:1
2The Appendix May Protect Against Clostridium difficile Recurrence显示文摘Gene Y. Im Rani J. Modayil Cheng T. Lin Steven J. Geier Douglas S. Katz Martin Feuerman James H. Grendell 2011Clinical Gastroenterology and Hepatology2011,,12:1
3Effects of sleep on wake-induced c-fos expression显示文摘Radhika B Jonathan ES James IM 1997J Neurosci1997,17,:1
4High yield of same-session EUS-guided liver biopsy by 19-gauge FNA needle in patients undergoing EUS to exclude biliary obstruction显示文摘Stavros N. Stavropoulos Gene Y. Im Zahra Jlayer Michael D. Harris Teodor C. Pitea George K. Turi Peter F. Malet David M. Friedel James H. Grendell 2012Gastrointestinal Endoscopy2012,,2:1
5Insulin resistance and cardiovascular disease显示文摘Samy IM Maryann B James RS 2000J Clin Endocrinol2000,86,2:1
6Insulin-Heparin Infusions Peritransplant Substantially Improve Single-Donor Clinical Islet Transplant Success显示文摘Angela Koh Peter Senior Abdul Salam Tatsuya Kin Sharleen Imes Parastoo Dinyari Andrew Malcolm Christian Toso Bo Nilsson Olle Korsgren A. M. James Shapiro 2010Transplantation2010,,4:1
7Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs.Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch 2017World Journal of Virology2017,6,4:1
8An Experimental Study of the Effects of Platinum on Methane/Air and Propane/Air Mixtures in a Stagnation Point Flow Reactor显示文摘Wiswall James T Wooldridge Margaret S Im Hong G 0,,11:1
9Insulin resistance and cardiovascular disesse显示文摘Sarny IM Maryann B James RS 2000J Clin Endocrinol2000,86,2:1
10Measurement of H2O2 within living drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix显示文摘COCHEME HM QUIN C MCQUAKER S J CABREIRO F LOGAN A PRIME T A ABAKUMOVA I PATEL J V FEARNLEY IM JAMES A M PORTEOUS C M SMITH ROBIN A J SAEED S CARRE J E SINGER M GEMS D ttARTLEY R C PAR- TRIDGE L MURPHY M P 2011Cell Metabolism2011,13,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费